Correlation Between Pasithea Therapeutics and Neurobo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Neurobo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Neurobo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Neurobo Pharmaceuticals, you can compare the effects of market volatilities on Pasithea Therapeutics and Neurobo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Neurobo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Neurobo Pharmaceuticals.
Diversification Opportunities for Pasithea Therapeutics and Neurobo Pharmaceuticals
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pasithea and Neurobo is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Neurobo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobo Pharmaceuticals and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Neurobo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobo Pharmaceuticals has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Neurobo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and Neurobo Pharmaceuticals
Given the investment horizon of 90 days Pasithea Therapeutics Corp is expected to under-perform the Neurobo Pharmaceuticals. In addition to that, Pasithea Therapeutics is 4.71 times more volatile than Neurobo Pharmaceuticals. It trades about -0.31 of its total potential returns per unit of risk. Neurobo Pharmaceuticals is currently generating about 0.58 per unit of volatility. If you would invest 211.00 in Neurobo Pharmaceuticals on November 3, 2024 and sell it today you would earn a total of 3.00 from holding Neurobo Pharmaceuticals or generate 1.42% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 14.29% |
| Values | Daily Returns |
Pasithea Therapeutics Corp vs. Neurobo Pharmaceuticals
Performance |
| Timeline |
| Pasithea Therapeutics |
| Neurobo Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pasithea Therapeutics and Neurobo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pasithea Therapeutics and Neurobo Pharmaceuticals
The main advantage of trading using opposite Pasithea Therapeutics and Neurobo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Neurobo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobo Pharmaceuticals will offset losses from the drop in Neurobo Pharmaceuticals' long position.| Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Virax Biolabs Group | Pasithea Therapeutics vs. Revelation Biosciences |
| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |